优化siRNA的长期稳定性使用热组合可反向电离的多元-Bcl2微粒复合体
Anindita De1, Ji Hee Kang2, Sauraj2
1College of Pharmacy, Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 21936, South Korea..
International journal of biological macromolecules
|March 12, 2024
概括
新的Thermosassemble电离式反向体 (TIRP) 纳米载体系统证明了用于癌症治疗的增强的siRNA传递. 这一创新的平台为质母细胞瘤治疗提供了更好的稳定性,有针对性的释放和血脑屏障透.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 之前的siRNA传递系统面临着稳定性和目标传递方面的挑战.
- 开发有效的纳米载体对于推进癌症基因治疗至关重要.
研究的目的:
- 开发和描述一种新的热组合电离反向体 (TIRP) 纳米载体,用于增强siRNA传递.
- 评估TIRP-Bcl2在向致癌途径和治疗质母细胞瘤方面的潜力.
主要方法:
- 自组装的TIRP-Bcl2到微粒结构与控制的纳米直径.
- 评估siRNA负载能力,体稳定性和释放型号.
- 对热敏反应行为的评估,以提高组织透和细胞吸收.
- 研究血脑屏障的运输能力.
主要成果:
- TIRP-Bcl2自组装成稳定的小粒 (75.8 ± 5.7 nm),具有高siRNA负载,在4°C稳定8个月.
- 在180小时内控制siRNA释放,并增强了癌细胞中的基因沉默功效.
- 已经证明能够穿越血脑屏障,显示出质母细胞瘤治疗的潜力.
- 热敏性质促进了更好的深层组织透和瘤微环境向.
结论:
- 提尔普平台为长期,稳定的siRNA输送提供了一个有前途的解决方案,具有增强的治疗潜力.
- TIRP-Bcl2对个性化癌症治疗,特别是质母细胞瘤的治疗有显著的前景.
- 这种创新的纳米载体系统需要进一步的研究和临床转化.
更多相关视频
08:53Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
7.7K
10:01Directed Assembly of Elastin-like Proteins into defined Supramolecular Structures and Cargo Encapsulation In Vitro
Published on: April 8, 2020
5.9K
相关概念视频
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...